Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B
Clinical trial NCT02366247 · UNKNOWN
Trial details
- NCT number
- NCT02366247
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.